Tag / Articles
-
Tackling the $3.1 Billion Corporate Fraud Problem with Continuous Monitoring Corporate fraud and white-collar crimes disrupt industries and erode public trust. -
How FinCEN’s New AML/CFT Rule Reshapes Due Diligence for Investment Advisers Effective January 1, 2026, this rule closes a gap in financial oversight frameworks by classifying IAs as financial institutions under the Bank Secrecy Act (BSA). IAs will now face full AML/CFT compliance for the first time. -
ExThera Case Exposes Immediate Investor Threat Due to Poor Startup Due Diligence In January 2025, The New York Times published an exposé by John Carreyrou on ExThera Medical, a California startup that allegedly repurposed its FDA-authorized COVID-19 blood filter for cancer treatment without regulatory approval. -
Drug Cartels Now Designated as Terrorist Organizations: New Sanctions Pose Major Business Risks The U.S. designated eight Latin American cartels as FTOs, imposing strict sanctions and compliance risks. -
Companies Bolster Onboarding Defenses against North Korean Threat Actors For years, North Korean threat actors have infiltrated U.S. firms by posing as remote IT workers, using stolen identities and AI-generated documents to secure jobs. -
Increased FCA Scrutiny on Private Equity’s Healthcare Investments The False Claims Act (FCA) has long protected consumers in healthcare. Now, regulators are expanding FCA liability to PE firms, placing them under increased scrutiny.